PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Jun-2025 U.S. biosimilar specialist Valorum Biologics LLC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® (aflibercept-mrbb) in the United States and Canada Formycon AG
24-Jun-2025 CureVac Announces Voting Results of General Meeting CureVac
24-Jun-2025 Strong demand for Formycon 2025/2029 Bond leads to early closing of subscription period Formycon AG
24-Jun-2025 Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025 Xlife Sciences AG
24-Jun-2025 Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Immunic AG
24-Jun-2025 Thermosome Reports Encouraging Clinical Data of THE001 in Advanced Soft Tissue Sarcomas Thermosome
23-Jun-2025 Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine Biotest AG
23-Jun-2025 Original-Research: CLINUVEL Pharmaceuticals (von Parmantier & Cie. GmbH) CLINUVEL Pharmaceuticals
23-Jun-2025 EAN 2025: Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® for the Prevention of Chronic and Episodic Migraine Teva Pharmaceutical
23-Jun-2025 Viromed Medical AG: Cold plasma technology shows potential to significantly reduce deaths in ventilated patients Viromed Medical AG
20-Jun-2025 Formycon bond 2025/2029: Public subscription now also possible via Deutsche Börse Formycon AG
20-Jun-2025 Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 Relief Therapeutics Holding SA
19-Jun-2025 Veranova Breaks Ground on ADC Facility Expansion at Devens, MA Veranova
19-Jun-2025 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
18-Jun-2025 Medios adopts public share buyback offer for up to 1 million shares at a price of EUR 12.50 Medios AG
18-Jun-2025 PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met PharmaSGP Holding SE
18-Jun-2025 Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities Formycon AG
18-Jun-2025 Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50 Eckert & Ziegler SE
18-Jun-2025 Formycon AG: Subscription period for 2025/2029 corporate bond has started Formycon AG
17-Jun-2025 Gerresheimer AG reacts to media reports Gerresheimer AG